OXYTETRACYCLINE Ca

OXYTETRACYCLINE CALCIUM

Get in touch with us!












      I accept conditions of use and privacy policy of this website.

    I want to receive updated information on the latest news.

    An overview

    Oxytetracycline Calcium is the calcium salt of Oxytetracycline, a substance produced by the growth of certain strains of Streptomyces rimosus or obtained by any other means. It is also a Tetracycline derivative with actions and uses like those of tetracycline. On the other hand, the antimicrobial action is like Tetracycline hydrochloride, but somewhat less active against many organisms.

    • Product Type: Tetracycline derivative
    • CAS Number: 15251-48-6
    • Common Indications: Pneumonia and other infections of the respiratory tract. Also in the treatment of Acne and Rosacea.
    • Product Status: Project under development.
    • Available Grades: Non-Micronized
    • Documentation: CoA, MSDS
    Oxytetracycline

    Advantages

    Efficacy:

    • Similar to tetracycline in action.
    • Bacteriostatic action over a wide range of bacteria.
    • Good safety profile and well tolerated.

    Safety:

    • Well and completely absorption.

    Finished
    Dosage forms

    Oxytetracycline and its salts have been applied topically, often in combinations with other agents, as a variety of eye and ear drops, syrup, ointments, creams and sprays.

    Global market status

    0 M

    consumed worldwide

    0 M

    USD global market sales in 2023 

    0 %

    Lorem ipsum solor

    Few API manufacturers to cover worldwide demand.

    Our API

    Oxitetracycline

    • Our API Oxytetracycline calcium is manufactured in accordance with cGMP and stringent international quality standards.

    Quality

    • Our quality control follows every stage from development of analytical methods to the control of manufacturing process.

    Samples availables

    destacado
    MINOCYCLINE

    PATENT PROTECTION

    Logo OFF

    Contact us & obtain the technical sheet












        I accept conditions of use and privacy policy of this website.

      I want to receive updated information on the latest news.